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Abstract Alpha-crystallin, a multimeric protein present in the 
eye lens, is known to have chaperone-like activity in preventing 
the aggregation of enzymes and other crystallins. We have stud- 
ied the chaperone-like activity of this protein towards the aggre- 
gation of insulin B chain, induced by reducing the interchain 
disulphide bond with dithiothreitol. At room temperature, there 
is no detectable protection (at a I: I  (wlw) ratio of insulin: tx- 
crystallin) against the aggregation of insulin B chain by ot-crys- 
tallin, whereas it completely prevents this aggregation at 40 ° C. 
We have monitored the temperature dependence of the protection 
of aggregation by a-crystallin; the protection increases harply 
above 30°C and reaches almost 100% by 41°C. Probing the 
hydrophobic surfaces of a-crystallin with the hydrophobic fluor- 
phore 8-anilino-I naphthalene sulfonate suggests that the hydro- 
phobic surfaces of a-crystallin are exposed to a greater extent 
above 30°C. A complete prevention of the aggregation is achieved 
at 27.6°C by increasing the concentration of a-crystallin by more 
than 8 fold. Similar temperature dependent chaperone-like activ- 
ity of a-crystallin is observed towards the aggregation of zeta- 
crystallin, an enzyme crystallin from guinea pig. We have earlier 
shown that a-crystallin exposes hydrophobic surface(s) at tem- 
peratures above 30°C. These results support our earlier hypothe- 
sis [Raman, B. and Rao, Ch.M. (1994) J. Biol. Chem. 269, 
27264-27268] that the chaperone-like activity of ot-crystallin is 
more pronounced in its structurally perturbed state. 
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I. Introduction 
Alpha-crystallin of the eye lens is a multimeric protein, made 
up of the two homologous gene products of ~A and %. It had 
been thought o be a lens specific, structural protein until a few 
years ago. Identification of this protein in several non-lenticular 
tissues such as heart, muscle and kidney [14] suggests that it 
might have a role to play in other functions. It is structurally 
related to small heat-shock proteins (Hsps), behaves in several 
ways like Hsps [5-8] and its expression can be induced by 
thermal [5] and osmotic stress [9]. Like some Hsps [1(~12] it is 
known to interact with membranes [13,14], cytoskeletal ele- 
ments [15,16], and to modulate the intermediate filament as- 
sembly [17]. Mixed assemblies of ~B and some Hsps have been 
observed both in vivo [18,19] and in vitro [8]. 
~-Crystallin isheat stable up to 100°C [20] and recent studies 
have shown that it exhibits chaperone-like activity in prevent- 
ing the aggregation of other proteins [21-26]. It binds ATP [27] 
and possesses autokinase activity [28]. Whether the chaperone- 
like activity of ~-crystallin has functional significance in the eye 
lens is not clear yet. However, the chaperone-like activity of 
~-crystallin has been shown to decrease on treatment with cal- 
pain II in vitro and in selenite induced cataract in vivo [29]. It 
is possible that ~-crystallin might chaperone the formation of 
transparent and refractive ye lens and also may help keep it 
that way by interacting with aged/damaged proteins [25]. Thus, 
one can speculate that failure of c~-crystallin may lead to loss 
of transparency as in cataract. 
We hypothesised that ~-crystallin prevents aggregation of 
non-native structures by providing appropriately placed hydro- 
phobic surfaces; a structural transition above 30°C enhances 
the protective ability, perhaps by increasing or reorganizing the 
hydrophobic surfaces [25]. In order to test our hypothesis and 
to have a better understanding of the chaperone-like activity of 
c~-crystallin, we have investigated the effect of c~-crystallin on 
the aggregation of B chain of insulin on treatment with dithio- 
threitol (DTT) and on the aggregation of zeta-crystallin, an 
enzyme crystallin from the eye lens of guinea pig. Results 
clearly support our hypothesis. Thus, structural perturbation 
appears to be important in the chaperone-like activity of 
c~-crystallin. 
2. Materials and methods 
2.1. Isolation and purification of ot-crystallin 
Fresh calf lenses were homogenized in Tris-HC1 buffer, pH 7.2, 
containing 100 mM NaC1, 1 mM EDTA, and 0.02% sodium azide and 
centrifuged at5000 x g at 4°C for 20 min. The soluble proteins in the 
supernatant were fractionated by gel filtration on a column of Bio-Gel 
A-1.5 m (1.8 x 180 cm) at 4°C. The fractions corresponding to ~L- 
crystallin (second peak) were pooled and concentrated at the above 
mentioned temperature byultrafiltration using an Amicon ultrafiltra- 
tion unit. The ~L concentrate was further purified by gel filtration on 
Bio-Gel A-5m column (1.8 x 180 cm), and the fractions were pooled 
and concentrated byultrafiltration asdescribed above. The concentrate 
of purified ~-crystallin was stored at -20°C until required. It is impor- 
tant to note that the sample was kept at or below 4°C during the entire 
isolation procedure in order to ensure that it remained in its higher 
molecular weight form. 
2.2. Preparation of zeta-crystallin 
Zeta-crystallin from guinea pig lens was purified using a Blue Sepha- 
rose CL-6B affinity column as described by Rao and Zigler [30]. Fresh 
guinea pig lenses were homogenized in Tris-HC1 buffer, pH 7.4, con- 
taining 0.5 mM EDTA and 5 mM fl-mercaptoethanol and centrifuged 
at 5000 x g for 15 min. The supernatant was loaded on a Blue Sepharose 
CL-6B column equilibrated with the homogenizing buffer. The bound 
zeta-crystallin was eluted with the homogenizing buffer containing 1 M 
NaC1 and desalted by dialysis against buffer. The zeta-crystallin iso- 
lated by this procedure was free from NADPH as tested by absorption 
spectroscopy. The purity of the zeta-crystallin was assessed by sodium 
dodecyl sulfate-polyacrylamide gel lectrophoresis and the protein con- 
centration was determined by the modified Lowry method [31]. 
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2.3. Assay Jbr protein aggregation 
Insulin at a concentration f 0.2 mg/ml (10 mM phosphate buffer, 
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pH 7.4, containing 100 mM NaCI) in the presence or absence of the 
required amount of ~-crystallin was equilibrated at the required tem- 
perature for 5 min with constant stirring in the sample holder using a 
Julabo thermostated water bath. The actual temperature of the sample 
in the cuvette was monitored by a Physitemp microthermocouple th r- 
mometer system. The reduction of insulin was initiated by adding 30 ~1 
of 1 M DTT to 1.5 ml of the sample and the extent of aggregation of
the insulin B chain was measured as a function of time by monitoring 
the scattering by setting the excitation and emission monochromator 
of the Hitachi F4000 fluorescence spectrophotometer at 465 nm with 
excitation and emission band passes of 1.5 nm. 
Thermal aggregation fzeta-crystallin was monitored by the follow- 
ing procedure. The buffer (10 mM phosphate buffer, pH 7.4, containing 
100 mM NaCI) was equilibrated atthe required temperature for 5 min 
with constant stirring in the sample holder as mentioned above. Then, 
60/A of 5 mg/ml zeta-crystallin solution was added to a final volume 
of 1.5 ml and the extent of aggregation was measured as a function of 
time by the scattering of 465 nm light as mentioned above. In 
another experiment the buffer containing 0.2 mg/ml ~-crystallin was 
equilibrated at the required temperature. Zeta-crystallin was then 
added and aggregation measured as described above. 
2.4. Fluorescence measurements 
c~-Crystallin (0.3 mg/ml) in 10 mM phosphate buffer, pH 7.4, contain- 
ing 100 mM NaCI was incubated with 20/~M of sodium 8-anilino-1- 
naphthalene sulfonate (ANS) at 20°C for 2 h. This sample was equili- 
brated at the required temperature in the sample holder of Hitachi 
F4000 fluorescence spectrophotometer using a Julabo thermostated 
water bath for 5 rain. The actual temperature of the sample was mon- 
itored as mentioned above. Fluorescence spectra were recorded with an 
excitation wavelength of 365 nm. The excitation and emission band 
passes were 3 nm and 1.5 nm, respectively. 
3. Results and discussion 
Upon reducing the disulphide bond between the two chains 
of insulin with reducing agents uch as dithiothreitol (DTT), the 
B chain of insulin aggregates and precipitates out leaving the 
A chain in solution [32]. Recently Farahbakhsh et al. have 
shown that c~-crystallin prevents the aggregation of insulin B 
chain at 25°C [26]. They have observed that the aggregation of 
insulin B chain is completely prevented at a weight ratio of 
ct-crystallin to insulin of more than 6: 1. It is interesting to note 
that ct-crystallin prevents the thermal aggregation of several 
proteins at 10 fold lesser concentrations than that of the target 
protein [21]. We have earlier shown that the chaperone-like 
activity of ~t-crystallin is enhanced at temperatures above 30 ° C. 
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Fig. 1. Aggregation of insulin B chain at (a) 27.6°C and (b) 40.6°C. 
Aggregation was monitored by measuring scattering of 465 nm light. 
( ) 0.2 mg/ml insulin alone, and at an insulin to c~-crystallin weight 
ratio of 1 : 1 ( - - - )  and 1 : 8 (...). 
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Fig. 2. Temperature d pendent prevention ofaggregation f insulin (0.2 
mg/ml) by c~-crystallin (0.2 mg/ml). Percentage protection iscalculated 
using the equation, ((Io-I~)/Io) x 100; where Io is the light scattering in
the absence and l~ in the presence of e-crystallin at a fixed time after 
initiation of the reaction with DTT. 
Thus, on the basis of our earlier studies, we expect a much 
better protection of aggregation by ~-crystallin at higher tem- 
peratures. To test our hypothesis and to gain an insight into the 
mechanism of the chaperone-like activity of ~-crystallin, we 
have investigated its ability to prevent the aggregation of insulin 
B chain as a function of temperature. 
The solid line in Fig. la shows aggregation of insulin (0.2 
mg/ml) with time on treatment with DTT as monitored by the 
scattering of 465 nm light at 27.6°C. The presence of ~-crys- 
tallin (0.2 mg/ml) does not prevent he aggregation of insulin 
B chain at 27.6°C (dashed line, Fig. la). On the other hand, if 
the experiment is conducted at a higher temperature (40.6°C) 
the result is very different. The aggregation is completely pre- 
vented by ct-crystallin (0.2 mg/ml) as shown in Fig. lb. Fig. 2 
shows the percentage protection as a function of temperature. 
As evident from the figure, c~-crystallin is functional only above 
30°C in preventing the aggregation of insulin B chain. We have 
earlier shown a similar transition at about 30°C in our studies 
on the effect of ct-crystallin on photo-aggregation f y-crys- 
tallin [25]. Gamma-crystallin aggregates upon irradiation with 
UV light [33]. Alpha-crystallin does not prevent his aggrega- 
tion at temperatures below 30°C. The percentage protection 
increases harply above 30°C. Walsh et al. have reported two 
endothermic transitions in the differential scanning calorimet- 
ric studies of c~-crystallin [34]. The sharp transition above 30 ° C, 
in all these studies, suggests a structural change in ~-crystallin 
which is responsible for its enhanced chaperone-like activity. 
Fig. 3 shows the change in the emission maximum of ANS 
bound to ~-crystallin with temperature. The emission maxi- 
mum is red shifted gradually above 30°C (and more sharply 
above 50°C), indicating that the ANS bound hydrophobic sur- 
faces of c~-crystallin are becoming exposed to water. Probing 
the hydrophobic surfaces in ~-crystallin with pyrene, we 
showed in our earlier study that the hydrophobic surfaces of 
~-crystallin are increasingly exposed above 30°C [25]. Figs. 2 
and 3 together suggest that a structural change(s) in c~-crystallin 
which exposes the hydrophobic surfaces is important for its 
chaperone-like activity. 
It is important to note that, in our present study, the aggre- 
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Fig. 3. Temperature dependent fluorescence of~-crystallin bound ANS 
(see section 2 for details). 
On the other hand, in our earlier study, the photo-aggregation 
of y-crystallin was prevented only about 60% at this tempera- 
ture. This comparison suggests that the extent of exposure of 
hydrophobic surfaces in the target proteins also plays a role in 
the chaperone-like activity. 
We have also studied the effect of varying weight ratio of 
a-crystallin to insulin at 27.6°C and at 40.6°C on the aggrega- 
tion of insulin B chain. Fig. 4 shows the variation of the per- 
centage protection with weight ratio. It is clear from the figure 
that protection increases dramatically at 40.6°C. Almost 100% 
protection isachieved with a 1 : 1 weight ratio, whereas at room 
temperature (27.6°C) even as high as 8 times more a-crystallin 
leads to only about 85% protection. Clearly a structural transi- 
tion (as we hypothesized) is bringing about at least an 8 fold 
increase in the effectiveness of a-crystallin as a chaperone. 
Zeta-crystallin from the eye lens of guinea pig binds NADPH 
and has quinone-reductase activity [35]. Rao et al. [24] have 
earlier shown that zeta-crystallin readily aggregates at41°C in 
the absence of the nucleotide NADPH and the aggregation 
temperature is postponed to about 55°C in the presence of the 
nucleotide. Binding of NADPH, thus, stabilizes zeta-crystallin. 
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Fig. 4. Effect of the relative concentration f ~-crystallin on its preven- 
tion of the aggregation of insulin B chain at (o) 27.6°C and at (e) 
40.6°C. The percentage protection was calculated using the equation 
mentioned in the legend to Fig. 2. 0.2 mg/ml of insulin was used and 
the ~-crystallin concentration was varied. 
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Fig. 5. Aggregation of 0.2 mg/ml zeta-crystallin i  the absence (--) and 
in the presence (- ) of 0.2 mg/ml a-crystallin at41°C (a) and at 55°C 
(b). Aggregation was measured by monitoring the scattering of 465 nm 
light. 
preventing the aggregation of zeta-crystallin at 41°C in the 
absence of NADPH and it completely prevents the aggregation 
ofzeta-crystallin at 55°C in the presence of the nucleotide. They 
have suggested that subtle changes in the conformation of zeta- 
crystallin upon its binding to NADPH is responsible for the 
observed ifferential protection of thermal-aggregation of zeta- 
crystallin by a-crystallin. Our results, on the other hand, sug- 
gest hat a structural change in ~-crystallin might be responsible 
for its differential chaperone-like activity. In order to verify this 
possibility, we have modified the experiment as mentioned in 
section 2. We believe that a-crystallin eeds to be in its temper- 
ature-perturbed state for it to be effective. Hence we kept the 
~-crystallin solution at 41 or 55°C and then added zeta-crys- 
tallin. We find that a-crystallin partially prevented the aggrega- 
tion of zeta- crystallin at 41 °C in the absence of NADPH (Fig. 
5a). It almost completely prevents the aggregation of zeta-crys- 
tallin at 55°C, again in the absence of NADPH, as evident from 
Fig. 5b. These results reinforce the importance of structural 
perturbation of ~-crystallin i its chaperone-like activity. 
We, therefore, conclude that a-crystallin prevents aggrega- 
tion of non-native structures by providing appropriately placed 
hydrophobic surfaces. A structural transition above 30°C en- 
hances the protective ability of a-crystallin, perhaps by increas- 
ing or reorganizing the hydrophobic surfaces. Since a-crystallin 
is known to undergo quaternary structural changes with tem- 
perature [36,37], such structural perturbation might be involved 
in the chaperone-like activity of a-crystallin. Brunschier et al. 
[38] have shown a similar temperature-dependent interaction 
between GroEL and phage p22 tailspike protein. Above 30 ° C, 
folding intermediates bind to GroEL, whereas below 25°C 
GroEL has no apparent interaction with the nascent protein. 
Hansen and Gafni have suggested that a sharp structural tran- 
sition is induced in GroEL by temperature [39]. It is, therefore, 
interesting to know whether all heat shock proteins (and 
chaperones) have similar temperature dependent function be- 
cause they are required to function more efficiently at non- 
permissible temperatures. 
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